Sunny Optical Technology (Group) Company Limited (FRA:SXC)
7.92
-0.13 (-1.60%)
Last updated: Aug 1, 2025
Intra-Cellular Therapies Market Cap
FRA:SXC has a market cap or net worth of €8.60 billion as of August 1, 2025. Its market cap has increased by 45.01% in one year.
Market Cap
8.60B
Enterprise Value
6.87B
Revenue
5.07B
Ranking
n/a
PE Ratio
24.09
Stock Price
$7.92
Market Cap Chart
Since June 15, 2007, FRA:SXC's market cap has increased from 307.72M to 8.60B, an increase of 2,696.07%. That is a compound annual growth rate of 20.15%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 8.60B | -8.19% |
Dec 31, 2024 | 9.37B | 4.68% |
Dec 29, 2023 | 8.95B | -26.47% |
Dec 30, 2022 | 12.18B | -59.99% |
Dec 31, 2021 | 30.43B | 55.47% |
Dec 31, 2020 | 19.57B | 15.96% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 289.34B |
Siemens Aktiengesellschaft | 176.66B |
Deutsche Telekom AG | 154.36B |
Allianz SE | 131.75B |
Rheinmetall AG | 79.50B |
Siemens Energy AG | 77.36B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 74.55B |
Deutsche Bank Aktiengesellschaft | 54.97B |